000132712 001__ 132712
000132712 005__ 20240229105028.0
000132712 0247_ $$2doi$$a10.1055/s-0038-1635106
000132712 0247_ $$2pmid$$apmid:29548059
000132712 0247_ $$2ISSN$$a0271-8235
000132712 0247_ $$2ISSN$$a1098-9021
000132712 0247_ $$2altmetric$$aaltmetric:70405608
000132712 037__ $$aDKFZ-2018-00366
000132712 041__ $$aeng
000132712 082__ $$a610
000132712 1001_ $$aFilbin, Mariella G$$b0
000132712 245__ $$aGliomas in Children.
000132712 260__ $$aNew York, NY$$bThieme Medical Publ.$$c2018
000132712 3367_ $$2DRIVER$$aarticle
000132712 3367_ $$2DataCite$$aOutput Types/Journal article
000132712 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1659695277_13805$$xReview Article
000132712 3367_ $$2BibTeX$$aARTICLE
000132712 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000132712 3367_ $$00$$2EndNote$$aJournal Article
000132712 520__ $$aGliomas are the most common primary central nervous system (CNS) neoplasms in children and adolescents and are thought to arise from their glial progenitors or stem cells. Although the exact cells of origin for most pediatric gliomas remain to be identified, our current understanding is that specific cell populations during CNS development are susceptible to particular oncogenic events during certain time windows and thus give rise to pediatric gliomas with distinct histological, molecular, and clinical features. These may be roughly segregated into low-grade gliomas (WHO grades I or II; including most mixed glial-neuronal tumors) and high-grade gliomas (WHO grades III or IV) according to their clinical course when untreated, even though this is not yet entirely clear for some of the recently emerging groups. The genetic and epigenetic characterization of pediatric gliomas across ages and histologies has facilitated the delineation of biologically relevant subgroups and have revealed potentially targetable alterations in some of them. This review outlines diagnostic features and molecular alterations in pediatric low- and high-grade gliomas and how the latter might be exploited with future targeted therapeutic strategies.
000132712 536__ $$0G:(DE-HGF)POF3-312$$a312 - Functional and structural genomics (POF3-312)$$cPOF3-312$$fPOF III$$x0
000132712 588__ $$aDataset connected to CrossRef, PubMed,
000132712 7001_ $$0P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807$$aSturm, Dominik$$b1$$eLast author$$udkfz
000132712 773__ $$0PERI:(DE-600)2072477-9$$a10.1055/s-0038-1635106$$gVol. 38, no. 1, p. 121 - 130$$n1$$p121 - 130$$tSeminars in neurology$$v38$$x1098-9021$$y2018
000132712 909CO $$ooai:inrepo02.dkfz.de:132712$$pVDB
000132712 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a46a5b2a871859c8e2d63d2f8c666807$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000132712 9131_ $$0G:(DE-HGF)POF3-312$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunctional and structural genomics$$x0
000132712 9141_ $$y2018
000132712 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000132712 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000132712 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000132712 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSEMIN NEUROL : 2015
000132712 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000132712 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000132712 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000132712 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000132712 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000132712 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000132712 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000132712 915__ $$0StatID:(DE-HGF)1120$$2StatID$$aDBCoverage$$bBIOSIS Reviews Reports And Meetings
000132712 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000132712 9201_ $$0I:(DE-He78)B062-20160331$$kB062$$lB062 Pädiatrische Neuroonkologie$$x0
000132712 9201_ $$0I:(DE-He78)L101-20160331$$kL101$$lDKTK Heidelberg$$x1
000132712 980__ $$ajournal
000132712 980__ $$aVDB
000132712 980__ $$aI:(DE-He78)B062-20160331
000132712 980__ $$aI:(DE-He78)L101-20160331
000132712 980__ $$aUNRESTRICTED